Skip to content

Photonic Needle and intraforaminal epidurale injection (sleeve) - observational study in humans (Sleeve 1 study)

Photonic Needle and intraforaminal epidurale injection (sleeve) - observational study in humans (Sleeve 1 study) - Sleeve 1 study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35392
Enrollment
33
Registered
2011-10-17
Start date
2011-10-25
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nerve pain radicular pain

Interventions

None listed

Sponsors

Philips
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Radicular pain - Patients* age is 18-80 years - Signed informed consent

Exclusion criteria

Exclusion criteria: - Pregnancy - Photodynamic therapy used before - Inability to give informed consent - Contrast fluid allergy - Any operation on the spine at the side of intervention - Coagulation disorders / disturbance - Infections at the level of intervention

Design outcomes

Primary

MeasureTime frame
The primary objective of this study is to investigate the potential of the photonic needle to discriminate between correct and incorrect placement of the needle tip in the target area of the procedure (M4 - tissue), as confirmed by contrast-enhanced fluoroscopy. The main study parameters are: 1) Successfully acquired diffuse reflectance spectra obtained at measurement point M4: midforaminal, halfway the foramen (the target treatment location) as encountered during image-guided intraforaminal injections on lumbar level. 2) Confirmation of target area with fluoroscopy and injection of contrast fluid (gold standard). 3) *Certainty score* on a 3-point scale (1 = uncertain, 2 = certain, 3 = very certain) will be provided by the physician. The type of tissue present at the needle tip will be based on the information available from imaging.

Secondary

MeasureTime frame
The secondary objectives are to investigate the differences in the optical signals obtained with the photonic needle at a set of different pre-defined positions (M1, M2 and M3) encountered along the needle trajectory during above-mentioned procedures, and to detect potential intravascular positioning of the needle-tip at the target point (M4 - blood). The secondary study parameters are: 1) Successfully acquired diffuse reflectance spectra obtained at measurement points M1-M3: M1 in muscle, M2 extra-foraminal, M3 foraminal at a distance 1/3 of the diameter of the foramen from the entrance of the foramen, as encountered during image-guided intraforaminal injections on lumbar level. 2) Successfully acquired diffuse reflectance spectra obtained at measurement point M4, in case of a vascular puncture (M4-blood) 3) Confirmation images by ultrasound imaging at location M1 as described above. 4) Confirmation images by fluoroscopy at locations M2 and M3. 5) Digital subtraction angiography images after contrast injection at location M4, confirming vascular penetration (gold standard for vessel puncture). 6) *Certainty score* on a 3-point scale (1 = uncertain, 2 = certain, 3 = very certain) provided by the physician for assignment of the type of tissue present at the needle tip, based on the information available from imaging at M1 and at M4-blood.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)